Form 4 filed by SR ONE CAPITAL MANAGEMENT, LLC
SR ONE CAPITAL MANAGEMENT, LLC filed this Form 4 on ADARx Pharmaceuticals, Inc. with 15 transaction rows and 0 holding rows, accepted by EDGAR 2026-09-30 01:45:43 UTC.
- Accession
- 0001193125-26-408064
- Filer
- CIK 1853723
- Filed
- 2026-09-29
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
Issuer and reporting owners
Issuer: ADARx Pharmaceuticals, Inc. (CIK 1802369)
- SR ONE CAPITAL MANAGEMENT, LLC 10% owner
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-09-28 | C converted | +3,334,938 | 3,334,938 | I See Note 2 | |
| Common Stock | 2026-09-28 | C converted | +1,113,666 | 4,448,604 | I See Note 2 | |
| Common Stock | 2026-09-28 | C converted | +512,897 | 4,961,501 | I See Note 2 | |
| Common Stock | 2026-09-28 | P bought | +592,593 | $17 | 5,554,094 | I See Note 2 |
| Common Stock | 2026-09-28 | C converted | +1,538,691 | 1,538,691 | I See Note 3 | |
| Common Stock | 2026-09-28 | P bought | +414,814 | $17 | 1,953,505 | I See Note 3 |
| Common Stock | 2026-09-28 | C converted | +1,667,468 | 1,667,468 | I See Note 4 | |
| Common Stock | 2026-09-28 | C converted | +169,001 | 1,836,469 | I See Note 4 | |
| Common Stock | 2026-09-28 | P bought | +592,593 | $17 | 592,593 | I See Note 5 |
| Series B Preferred Stock derivative | 2026-09-28 | C converted | -3,907,547 | $0 | 0 | I See Note 2 |
| Series B-1 Preferred Stock derivative | 2026-09-28 | C converted | -1,304,883 | $0 | 0 | I See Note 2 |
| Series C Preferred Stock derivative | 2026-09-28 | C converted | -600,962 | $0 | 0 | I See Note 2 |
| Series C Preferred Stock derivative | 2026-09-28 | C converted | -1,802,885 | $0 | 0 | I See Note 3 |
| Series B Preferred Stock derivative | 2026-09-28 | C converted | -1,953,773 | $0 | 0 | I See Note 4 |
| Series B-1 Preferred Stock derivative | 2026-09-28 | C converted | -198,019 | $0 | 0 | I See Note 4 |